SCNI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Scinai Immunotherapeutics Ltd (SCNI) is not a good buy at the moment for a beginner investor with a long-term focus. The technical indicators are bearish, the financial performance is weak, and there are no positive catalysts or trading signals to support a buy decision. The stock is oversold, but the lack of significant upward momentum or positive sentiment makes it unsuitable for investment right now.
The stock is in a bearish trend with MACD negatively expanding below 0, RSI at 9.672 indicating oversold conditions, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). Key support levels are at 0.585 and 0.536, with resistance at 0.666 and 0.746.
NULL identified. No recent news or significant trading trends to act as a positive catalyst.
Weak financial performance, with net income dropping by -4.29% YoY and EPS down by -100.00% YoY. Gross margin remains negative at -164.29%. Technical indicators are bearish.
In Q4 2024, revenue remained flat at $206,000 YoY. Net income dropped to -$2,230,000 (-4.29% YoY), and EPS fell to 0 (-100.00% YoY). Gross margin is negative at -164.29%. Overall, the financials show no growth and worsening profitability.
No analyst rating or price target changes available.
